UK

Umesh Kumar

Active Director Director DIN 09795987
DIN 09795987 First appointment Nov 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value •••• Premium profile

About Umesh Kumar

Data last updated:

Umesh Kumar is a Director at Beopt Biotech Private Limited (since 2022). The company operates in Healthcare. Beopt Biotech Private Limited reported revenue of ₹64.6 Lakh (FY 2025).

DIN 09795987
Primary Designation Director
Industry Healthcare
First Appointment 13 Nov 2022
Oldest Company Age 12 yrs
Largest company Beopt Biotech Private Limited · ₹64.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Beopt Biotech Private Limited U74900BR2014PTC022623
Director13 Nov 20222014₹64.6 Lakh (FY 2025)Active

Board colleagues of Umesh Kumar

Directorship timeline

Open interactive timeline →
Beopt Biotech Private Limited
Premium access

Shareholding and investment profile for Umesh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Umesh Kumar

Umesh Kumar currently holds 1 directorship: Beopt Biotech Private Limited (Director, since 13 Nov 2022, revenue ₹64.6 Lakh (FY 2025)).

Umesh Kumar was first appointed on 13 Nov 2022 as Director at Beopt Biotech Private Limited.

The current boards of Umesh Kumar's companies include Mamta Sinha (Beopt Biotech Private Limited), Prakash Chandra Verma (Beopt Biotech Private Limited), Shiwani Anil Thakur (Beopt Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available